大麻素治疗面部和上四分之一的疼痛:治疗潜力的系统评估
Karolina Walczyńska-Dragon1, Jakub Fiegler-Rudol2, Aleksandra Nitecka-Buchta1
1Department of Temporomandibular Disorders, Medical University of Silesia in Katowice, 41-800 Zabrze, Poland.
Journal of clinical medicine
|June 26, 2025
概括
大麻二醇 (CBD) 在上四分之一疾病中对慢性肌肌肌痛有希望,提供止痛和抗炎功效. 需要进一步的研究来证实疗效,并建立最佳使用的条件,如TMDs.
科学领域:
- 药理学 药理学是指药理学的学科.
- 疼痛管理 疼痛管理
- 大麻素研究 研究 大麻素研究
背景情况:
- Cannabidiol (CBD) 是一种非有毒的植物性大麻素,目前正在针对上四分之一疾病的疼痛和炎症进行研究.
- 这些疾病包括关节障碍 (TMD),口腔面部疼痛,肌肉面部功能障碍和牙痛.
研究的目的:
- 系统地审查CBD在管理上季度疼痛和炎症方面的疗效和安全性.
- 评估临床,临床前和机械学研究.
主要方法:
- 对10项研究 (RCT和动物模型) 的系统审查.
- 评估方法质量和偏差风险.
- 分析CBD对疼痛,炎症和肌肉放松的影响.
主要成果:
- CBD在慢性肌肌肌关节TMD和牛症中表现出止痛,抗炎和肌肉松作用,特别是在局部/内口使用时.
- 对于急性可感性疼痛,发现了不一致的结果.
- 在临床前模型中,CBD与传统止痛药显示出协同作用的潜力.
- 在CBD应用和结果措施中的异质性有限的比较.
- 副作用是最小的,但在临床试验中报告不足.
结论:
- 早期证据表明,CBD可能是一种有效的辅助治疗慢性肌关节疼痛在上季度的条件.
- 需要高质量,特定条件的试验来规范CBD剂量,输送和评估长期安全性.
相关概念视频
01:21Chemotherapy-Induced Nausea and Vomiting: Cannabinoids
371
Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Two synthetic agonists of THC,...
371
01:25Analgesia and Pain Management
822
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
822